OTC Markets Group Welcomes Arch Therapeutics to OTCQB

OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced Arch Therapeutics, Inc. (OTCQB: ARTH) is verified for trading on OTCQB®, the venture marketplace for entrepreneurial and development stage companies, effective October 31, 2014. Arch Therapeutics is a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care.  Arch is developing products based on an innovative self-assembling peptide technology platform to make surgery and interventional care faster and safer for patients.  Arch s flagship development stage product candidate, known as the AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in minimally invasive and open surgical procedures. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company onwww.otcmarkets.com. About OTC Markets Group Inc. OTC Markets G
http://bit.ly/10aDXKU